RxDoctor Payments Data

Ronald Mann, MD

Procedural Dermatology · Tucson, AZNPI 1902845738

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.1% of the total across 196 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Johnson & Johnson at 30.0% of the total.

$4,780in general payments, 2019–2025

Across 196 payments — averaging $24.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AbbVie$676
  • Regeneron Healthcare Solutions, Inc.$504
  • Sanofi$411
  • Galderma Laboratories, L.p.$302
  • Sun Pharmaceutical Industries Inc.$211
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$4,40192%
  • Education$3808%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few procedural dermatology providers in Arizonato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$482,579
Medicare patients
482
Services billed
4,630

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole75$894
Doxycycline Hyclate27$791
ValacyclovirValacyclovir Hcl14$769
Metronidazole12$453
Econazole Nitrate18$284
Mupirocin39$276
ErythromycinErythromycin Base20$262
Fluocinonide12$218
Triamcinolone Acetonide61$197
Cephalexin14$68
Amoxicillin15$34

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →